

Prompt A — SEA / Malaysia Regulatory & Compliance 

Section 1: Regulatory Requirements & System Actions 

|Requirement|Jurisdiction|Source+URL|What my system must do|Confidence|
|---|---|---|---|---|
|Explicit Consent for<br>Health Data|Malaysia|Personal Data<br>Protection Act2010<br>(Act709),s. 40|Obtain distinct,unbundled,afirmative opt-in consent before<br>processing physical/mental health condition details;separate from<br>general terms of service.|High|
|Biometric&Sensitive<br>Data Classifcation|Malaysia|PDPA Amendment<br>Act2024 (Act A1727)|Treat voice recordings,facial scans,and health intakes as Sensitive<br>Personal Data requiring explicit consent and heightened access<br>encryption.|High|
|Mandatory Breach<br>Notifcation|Malaysia|PDPA s. 12B/JPDP<br>Guidelines2024–<br>2025|Trigger automated incident triage to notify the PDP Commissioner<br>within72hours and alert afected users without undue delay if<br>health data is compromised.|High|
|Data Protection||PDPA2024|Formally designate and register a DPO if processing sensitive||
|Ofcer(DPO)<br>Appointment|Malaysia|Amendment/DPO<br>Guidelines|health data of<br> 10,000data subjects or performing systematic<br>tracking.|High|
|Cross-Border<br>Transfer Restrictions|Malaysia|PDPA2010,s. 129 /<br>2024Amendment|Host data locally or verify adequate jurisdiction/contractual<br>clauses(e.g.,standard data clauses)before routing intake chats<br>through foreign cloud servers(e.g.,US LLMs).|High|
|Medical Ad Pre-<br>Approval&<br>Testimonial Ban|Malaysia|Medicines<br>(Advertisement and<br>Sale)Act1956 &MAB<br>Guidelines|Restrict intake chat and public-facing widgets from displaying<br>patient testimonials,unapproved before/a�er imagery,superlative<br>claims("best/cure"),or unauthorized condition promos.|High|
|Prohibition of Non-<br>Clinician<br>Telemedicine|Malaysia|Telemedicine Act<br>1997 (Act564),s. 3|Hardcode bot boundaries to purely non-diagnostic administrative<br>intake and general health literacy;disclaim non-doctor status and<br>route clinical queries to registered practitioners.|High|
|Healthcare Services<br>Ad Licensing|Singapore|Healthcare Services<br>(Advertisement)<br>Regulations2021|Ensure all public acquisition flows display the clinic's oficial HCSA<br>licensee name/number,avoid comparative/superlative claims,and<br>avoid ofering unvetted financial inducements.|High|



# Section 2: Malaysian PDPA Consent Notice Dra� 

- "By tapping 'Agree & Continue', you give explicit consent under Malaysia's Personal Data Protection Act (PDPA) to [Clinic Name] and [Platform Name] to collect, store, and process the contact and health information you share in this chat. 

- We use this information solely to assess your inquiry, coordinate your appointment, and provide general health information. We do not sell your data or use it for unsolicited marketing. Your data is encrypted and accessible only to authorized clinic staff. You may withdraw consent or request deletion at any time by messaging 'STOP' or emailing dpo@[clinicdomain].my." (98 words) 

# Section 3: Recommended Data-Retention Schedule 

- Anonymous Website Metadata (14–30 Days): 

- Session telemetry, IP addresses, and traffic analytics are purged a�er 30 days because short retention sufficiently mitigates abuse while preventing aggregate re-identification under privacy guidelines. Unauthenticated Guest Chat Transcripts (7 Days): 

- Health disclosures volunteered by drop-off leads who never book an appointment are permanently wiped within 7 days, honoring the PDPA "no longer than necessary" standard while minimizing liability. Authenticated Patient Intake Records (7 Years): 

- Intakes transitioning to completed clinic bookings are retained for 7 years to comply with statutory Malaysian Private Healthcare Facilities and Services Act (PHFSA 1998) medical record-keeping mandates. Audit Logs & Consent Records (2 Years Post-Data Destruction): 

- Immutable transaction timestamps and consent-change receipts are retained for 24 months a�er chat deletion to defend against regulatory inquiries and demonstrate PDPA compliance. 

Section 4: Top 5 Regulatory Shutdown / Fine Risks 

1. AI Crossing into Unauthorized Clinical Diagnosis: 

- Generating automated triage diagnoses or prescribing specific medical advice via AI without a Malaysianregistered doctor violates the Telemedicine Act 1997 (Act 564) and Medical Act 1971, carrying severe penal liabilities. 

2. Failure to Report a Sensitive Health Data Breach: 

- Failing to notify the PDP Commissioner under the PDPA Amendment Section 12B when personal health information is breached risks statutory fines up to RM 1,000,000. 

3. Publishing Unapproved Health Claims or Testimonials: 

- Deploying patient endorsements, "guaranteed results," or before-and-a�er photos in acquisition ad funnels without Medicine Advertisements Board (MAB) vetting violates the Medicines (Advertisement and Sale) Act 1956. 

4. Illegal Cross-Border Exfiltration of Health Data: 

- Streaming unredacted, personally identifiable patient health chats to foreign third-party API servers without adequacy documentation or explicit PDPA cross-border consent mechanisms violates PDPA s. 129. 

5. Bundled or Inferred Consent for Direct Marketing: 

- Using volunteered intake phone numbers for outbound clinic promotions without separate opt-in consent breaches direct marketing protections under the PDPA. 

# Section 5: Regional Divergences (SG, ID, TH, PH) 

- Singapore (HCSA & PDPA): Unlike Malaysia's MAB pre-approval regime, Singapore operates on a strict postmarket enforcement framework under the Healthcare Services (Advertisement) Regulations 2021. Testimonials, celebrity endorsements, and comparative claims remain strictly prohibited. The single biggest divergence from Malaysia is Singapore's aggressive enforcement on telemedicine accountability and mandatory HCSA provider licensing transparency. 

- Indonesia (PDP Law No. 27/2022): A Malaysia-compliant architecture satisfies Indonesia's general data protection baseline, as both classify health data as specific/sensitive data requiring explicit consent. The single biggest gap is Indonesia's strict statutory data breach timeline (72 hours max) and government data sovereignty/localization rules for public sector and electronic service operators (PSE registration under Kominfo/MOH SATUSEHAT interoperability requirements). 

- Thailand (PDPA B.E. 2562): A Malaysian design is broadly compliant because Thailand's sensitive data framework directly mirrors GDPR Section 9 explicit-consent principles. The single biggest gap is Thailand's stringent cross-border transfer baseline (Section 28/29 standard contractual clauses) and criminal penalties (including potential imprisonment) for unlawful disclosure of health records causing public defamation. 

- Philippines (Data Privacy Act of 2012 / NPC): A Malaysia-aligned engine transfers smoothly, as health information is treated as Privileged/Sensitive Personal Information. The single biggest gap is the National Privacy Commission's (NPC) strict requirement for mandatory automated registration of data processing systems and the formal requirement to notify both the Commission and data subjects within 72 hours for highrisk sensitive data breaches. 

# Prompt B — Platform Policy for Social Acquisition Channels 

Section 1: Channel Capability & Automation Matrix 

|Channel|Can I<br>automate<br>it?|API/Webhook Name|Approval Needed|
|---|---|---|---|
|Instagram<br>DM from<br>Post<br>Comment|Yes|Webhook:<br>instagram_manage_comments /Graph API<br>POST/{comment-id}/replies|Meta App Review<br>(<br>instagram_manage_messages,<br>pages_manage_metadata)|
|Facebook<br>Messenger<br>Comment<br>Reply|Yes|Webhook:<br>feed /Graph Endpoint<br>POST/{comment_id}/private_replies|Meta App Review<br>(<br>pages_messaging,<br>pages_read_engagement)|
|WhatsApp<br>Business<br>Chat|Yes|Cloud API:<br>POST/v21.0/{phone_number_id}/messages|Meta Business Verification&Template<br>Approval|
|TikTok<br>Business<br>Messaging|Partially<br>(restricted)|Webhook:<br>im.message.receive /Direct Messaging API|Enterprise API whitelist+TikTok App<br>Approval|



Approval Needed Google Business Profile API OAuth Verification 

|Channel|Can I<br>automate<br>it?|API/Webhook Name|
|---|---|---|
|Google|||
|Business<br>Profle<br>Review|Yes(Public<br>reply only)|POST<br>/v4/accounts/{accountId}/locations/{locationId}/reviews/{reviewId}/reply|
|Replies|||



Section 2: Grey-Zone Compliance & Ethics Evaluation 



<!-- Start of picture text -->
Strategy Technical PDPA(MY) PlatformTerms PatientTrust One-Line Justification Green Design Remedy<br>1.Competitor Reviews Scraping � Green � Red � Red � Red Web scraping breaches GoogleTerms of Service, and contacting N/A (Intrinsically non-<br>scraped leads violates direct compliant)<br>for Unhappy Patients marketing and consent rules.<br>Meta strictly bans group scraping<br>2. Monitoring Public and automated unprompted N/A (Intrinsically non-<br>Health Groups to DM � Green � Red � Red � Red DMs, generating severe<br>compliant)<br>Symptom Posters harassment and privacy<br>backlash.<br>Meta explicitly bans retargeting Shi� to contextual search ads<br>3. Inferred Condition � Green � Red � Red � Red custom audiences built on based on keywords rather<br>Ad Retargeting sensitive health conditions or than behavioral audience<br>pixel health-event telemetry. retargeting.<br>4.Who Like a Health Auto-DMing Users � Red � � Red � Red Meta API does not provide DMsfor "Likes"; manual outreach Place a prominent Message" Call-To-Action"Send<br>Post Yellow feels intrusive and violates button directly on the post<br>platform anti-spam rules. instead.<br>5. Auto-DMing Automated public-to-private Respond with a neutral, non-<br>Commenters onStigmatized Health � Green �Yellow � Yellow �Yellow DMs on sensitive topics cantrigger privacy concerns if clinical greeting that lets theuser opt in before discussing<br>Posts notifications expose health health matters.<br>issues.<br><!-- End of picture text -->

# Section 3: High-Performing Compliant Acquisition Channels 

1. Click-to-WhatsApp (CTWA) via Contextual Meta Ads: 

- Running ads optimized for the "Send WhatsApp Message" objective routes users directly into the clinic's encrypted WhatsApp channel. 

- Policy Basis: The conversation is initiated by the user tapping the ad, opening a 24-hour customer service ' 

- window that complies with Meta s Business Messaging Policy without requiring prior templates. 

2. Google Search Intent with Direct Intake Scheduling Links: 

- Capturing high-intent search traffic with verified Google Healthcare Ads driving traffic to a zero-party landing page intake. 

- Policy Basis: Google Ads allows licensed providers to bid on symptom/treatment search queries when properly certified, bypassing the need for unsolicited outreach. 

3. Verified Organic Instagram Stories with "Send Message" Stickers: 

- Publishing educational health content featuring interactive prompt stickers invites users to engage voluntarily. Policy Basis: A user tapping an interactive Story sticker creates an explicit inbound webhook event under Meta Graph API policy, enabling personalized and compliant introductory chats. 

⁂ 

1. <u>https://pharmacy.moh.gov.my/en/documents/medicine-advertisements-board-mab-guidelines-and-policy.html</u> 2. <u>https://www.mayerbrown.com/en/insights/publications/2025/07/from-legislative-reform-to-practical-guidance-key-amendments-to-malaysiaspdpa-and-the-launch-of-cross-border-transfer-guidelines</u> 3. <u>https://www.dlapiperdataprotection.com/index.html?t=law&c=MY</u> 4. <u>https://practiceguides.chambers.com/practice-guides/data-protection-privacy-2026/malaysia/trends-and-developments/O24504</u> 5. <u>https://rsisinternational.org/journals/ijriss/articles/recent-reforms-to-the-personal-data-protection-act-2010-and-its-implications-for-business-o rganisations-in-malaysia/</u> 6. <u>https://www.dataprotectionreport.com/2024/07/malaysia-introduces-watershed-amendments-to-personal-data-protection-act-2010/</u> 7. <u>https://gltlaw.my/personal-data-protection-2024-what-you-need-to-know/</u> 8. <u>https://sso.agc.gov.sg/SL/HSA2020-S1033-2021?DocDate=20230621</u> 9. <u>https://www.moh.gov.my/moh/attachments/1205.pdf</u> 10. <u>https://sso.agc.gov.sg/SL/HSA2020-S1033-2021?DocDate=20230621&ViewType=Pdf&_=20240126145622</u> 

|11.<br>https://www.moh.gov.my/images/04-penerbitan/akta-kesihatan/telemedicine act1997.pdf|
|---|
|12.<br>https://pharmacy.moh.gov.my/en/documents/medicines-advertisement-sale-act-1956-and-regulations.html|
|13.<br>https://www.moh.gov.sg/newsroom/non-licensed-healthcare-entities-not-permitted-to-make-advertising-claims/|
|14.<br>https://isomer-user-content.by.gov.sg/7/2591b7d2-917e-45ae-83ce-dd769b1e2a64/MOH Cir87_2024Annex A Extracted Updates to FAQs on HCS<br>(Advertisement)Regulations.pdf|
|15.<br>https://isomer-user-content.by.gov.sg/7/1d84b66a-5625-49a2-8c0e-e06eea4ed9fd/FAQs on HCS(Advertisement)Regulations_1.1.pdf|
|16.<br>https://isomer-user-content.by.gov.sg/7/72a967ab-3994-4beb-b5ec-6958dd8d22fd/MOH Cir87_2024Joint Circular on Regulations and|
|Professional Standards for Telemedicine Services and Advertisements.pdf|
|17.<br>https://isomer-user-content.by.gov.sg/7/a2d9019f-7617-40f1-8788-7e105b0a77e9/12-10-2023-advert-regs-faqs-(1).pdf|
|18.<br>https://www.ams.edu.sg/view-pdf.aspx?file=media\4785_fi_705.pdf&ofile=Revised+Publicity+Explanatory+Guidance+Final+Version.pdf|
|19.<br>https://en.wikipedia.org/wiki/Telemedicine_Act_1997|
|20.<br>https://www.globalcompliancenews.com/2024/01/18/https-insightplus-bakermckenzie-com-bm-healthcare-life-sciences-singapore-ministry-of-<br>health-investigating-potential-breaches-of-advertising-guidelines_27122023/|
|21.<br>https://www.msc.com.my/cyberlaws/telemedicine-act.html|
|22.<br>https://www.scribd.com/document/72218050/Telemedicine-Act-1997-Act-564|
|23.<br>https://www.pdp.gov.my/ppdpv1/wp-content/uploads/2024/11/Act-A1727.pdf|
|24.<br>https://xaviertan.co/hcsa-advertising-guidelines/|
|25.<br>https://pharmacy.moh.gov.my/sites/default/files/document-upload/medicine-advertisement-sale-act-1956-act-290.pdf|
|26.<br>https://pharmacy.moh.gov.my/sites/default/files/document-upload/advertising-guidelines-healthcare-facilities-and-services-mab-3.2023.pdf|
|27.<br>https://pharmacy.moh.gov.my/sites/default/files/document-upload/latest-guideline-advertising-medicines-and-medicinal-products-general-pub<br>lic.pdf|
|28.<br>https://www.pdp.gov.my/ppdpv1/wp-content/uploads/2025/08/JPDP-FSB-190824-DBN-PCP-ENG-TC.pdf|
|29.<br>https://hq.moh.gov.my/tcm/en/index.php/guideline/guidelines-for-traditional-and-complementary-medicine-healthcare-facilities-and-service-i<br>n-malaysia|
|30.<br>https://www.pwc.com/my/en/assets/publications/2024/pwc-my-pdpa-bills-key-consideration.pdf|



